Endometrial cancer laboratory findings

Endometrial cancer Microchapters
Home
Patient Information
Overview
Historical perspective
Classification
Pathophysiology
Causes
Differentiating Endometrial cancer from other Diseases
Epidemiology and Demographics
Risk factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Endometrial cancer laboratory findings On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Endometrial cancer laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Endometrial cancer laboratory findings
CDC on Endometrial cancer laboratory findings
Endometrial cancer laboratory findings in the news
Blogs on Endometrial cancer laboratory findings
Directions to Hospitals Treating Endometrial cancer
Risk calculators and risk factors for Endometrial cancer laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]

Overview

The laboratory findings associated with endometrial carcinoma are the following: CBC, serum CA-125 concentration, liver function tests, and pulmonary function tests.

Endometrial Cancer Laboratory Findings

• Complete blood count and differential count,anemia
• Serum CA-125 -The tumor marker is checked, since this can predict advanced stage disease.
• Hypercalcemia may be present due to metastasis to the bone
• Abnormal liver function tests may be present due to metastasis to the liver
• Abnormal pulmonary function testsmay be present due to metastasis to the lung

References

Template:WikiDoc Sources